Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

05 June 2023

Access to medical oxygen: Why are we holding our breath?

In an op-ed for gasworld, Marijn Verhoef, Director of Operations and Research at the Access to Medicine Foundation, writes about the critical role of gas companies in addressing persistent gaps in access to medical oxygen in low- and middle-income countries (LMICs).

Direct links

Read the article

In this piece, Marijn discusses what gas companies that produce medical oxygen have done to scale up access to this lifesaving product. Using the findings from a research report, recently published by the Foundation's Medical Oxygen Programme, he sets out how these companies need to go further to address the chronic, longstanding shortages still faced in LMICs.

He notes that other stakeholders also have a role to play in creating conditions to enable a sustainable supply of medical oxygen, but underlines that "gas companies need to fully step into their role as unique and essential players within the global health ecosystem".

"What these companies have achieved so far has been disjointed and limited in geographic reach – with clear commitments for a systematic approach lacking."

You can read the full article here.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved